相关实验视频
Updated: May 11, 2026

06:06
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
帕金蛋白的结构揭示了泛素酶激活的机制
Jean-François Trempe1, Véronique Sauvé, Karl Grenier
1McGill Parkinson Program, Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montréal, Québec, Canada.
概括
研究人员阐明了帕金蛋白的结构,揭示了其自身抑制状态. 了解帕金森激活的这种机制为增强其在帕金森病中的神经保护功能提供了一条途径.
科学领域:
- 神经科学是一个神经科学.
- 结构生物学 结构生物学
- 遗传学 是一个遗传学.
背景情况:
- 在PARK2基因的突变导致自体逆向帕金森病.
- 帕金蛋白是一种E3泛基因酶,其基底活性较低.
- 帕金在神经元健康中起着至关重要的作用,具有神经保护作用.
研究的目的:
- 为了确定全长老鼠的晶体结构.
- 阐明帕金斯自身抑制和激活机制的结构基础.
- 为开发增强帕金活动策略提供框架.
主要方法:
- 进行X射线晶体学,以获得全长老鼠的结构.
- 在体外评估帕金活性的生物化学测试.
- 基于细胞的测试来评估突变对帕金斯功能的影响.
主要成果:
- 晶体结构显示了帕金在一个自抑制的形状.
- 发现RING0阻塞了RING2.2中的泛素受体部位.
- 观察到一个抑制元件可以结合RING1,阻断E2结合部位.
- 破坏这些抑制相互作用的突变导致了体外和细胞内帕金激活.
结论:
- 这项研究提供了对帕金-E3泛基因酶自身抑制和激活的第一个结构性见解.
- 了解这些机制对于开发针对帕金森病的治疗策略至关重要.
- 这些发现为增强帕金斯神经保护活性提供了结构和机制基础.
相关概念视频
Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome Structure
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...

